Cipta Sarana Medika Tbk. vs Maxindo Karya Anugerah Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Maxindo Karya Anugerah Tbk. trades at Rp50 (market cap 480.5B, 46.4K 24h volume). The key difference: Maxindo Karya Anugerah Tbk. is far larger — about 3× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (8.21M versus 46.4K). Which is the better fit depends on your goals.
| DKHH | MAXI | |
|---|---|---|
Market Cap | 158.12B | 480.5B |
Volume | 8.21M | 46.4K |
Lot | 82.15K | 464 |
Turnover | 515.2M | 2.32M |
Average Price | 62.72 | 50 |
Value | 515.2M | 2.32M |
Indicative Equilibrium Price | 63 | 50 |
Indicative Equilibrium Volume | 1.33K | 9 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Maxindo Karya Anugerah Tbk (the Company) was established based on Notarial Deed No. 26 of Dwi Swandiani, S.H., dated July 11, 2002. The Company started its commercial operations in 2002.
Read more on MAXI →